- Home
- SBET vs PHIO Comparison
SBET vs PHIO Comparison
Compare SBET & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- PHIO
- Stock Information
- Founded
- SBET 1995
- PHIO 2011
- Country
- SBET United States
- PHIO United States
- Employees
- SBET N/A
- PHIO N/A
- Industry
- SBET Computer Software: Prepackaged Software
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- SBET Technology
- PHIO Health Care
- Exchange
- SBET Nasdaq
- PHIO Nasdaq
- Market Cap
- SBET 618.0M
- PHIO 11.9M
- IPO Year
- SBET 1997
- PHIO N/A
- Fundamental
- Price
- SBET $23.88
- PHIO $2.41
- Analyst Decision
- SBET
- PHIO Strong Buy
- Analyst Count
- SBET 0
- PHIO 2
- Target Price
- SBET N/A
- PHIO $9.00
- AVG Volume (30 Days)
- SBET 28.5M
- PHIO 191.8K
- Earning Date
- SBET 08-14-2025
- PHIO 08-13-2025
- Dividend Yield
- SBET N/A
- PHIO N/A
- EPS Growth
- SBET N/A
- PHIO N/A
- EPS
- SBET N/A
- PHIO N/A
- Revenue
- SBET $3,428,134.00
- PHIO N/A
- Revenue This Year
- SBET N/A
- PHIO N/A
- Revenue Next Year
- SBET N/A
- PHIO N/A
- P/E Ratio
- SBET N/A
- PHIO N/A
- Revenue Growth
- SBET N/A
- PHIO N/A
- 52 Week Low
- SBET $2.26
- PHIO $0.97
- 52 Week High
- SBET $124.12
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- SBET 57.77
- PHIO 53.21
- Support Level
- SBET $9.18
- PHIO $2.31
- Resistance Level
- SBET $12.03
- PHIO $2.62
- Average True Range (ATR)
- SBET 2.40
- PHIO 0.15
- MACD
- SBET 1.45
- PHIO -0.01
- Stochastic Oscillator
- SBET 79.88
- PHIO 58.82
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.